Worth reading
58In focus
Scored from 4 of 5 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Agreements reached under this partnership
Establishment of a joint venture7649SUGI HOLDINGS Co.,LTD.
Alliance partnerAC HEALTH PHARMA VENTURES, INC. / JOLECO RESOURCES, INC.
Details of the alliance
- 1
Support for importing our products and obtaining product registrations
- 2
Providing access to suppliers
- 3
Providing expertise in marketing and store development in the Philippine market
- 4
Establishment and operation of concept stores
- 5
Sales of pharmaceuticals, health foods, cosmetics and other products
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
Capital and personnel relationships
This indicates whether the companies will do more than work together, such as holding each other’s shares or seconding personnel (capital and business alliance).
Ownership ratioOur company 40%, APV 40%, JRI 20%
Overview of the joint ventureName AJS Pharma, Inc. / Location 3rd Floor Makati Stock Exchange Building, 6767 Ayala Avenue, Makati City, Philippines / Business Description Establishment and operation of concept stores, and sales of pharmaceuticals, health foods, cosmetics and other products / Capital Contributions Not disclosed / Ownership ratio Our company 40%, APV 40%, JRI 20%
About the partner
Business DescriptionOperation of an integrated pharmaceutical network with a portfolio spanning the entire pharmaceutical value chain, including pharmaceutical imports, wholesale distribution and retailing / Operation of the St. Joseph Drug pharmacy chain in northern and central Luzon, Philippines, as well as the retail and wholesale distribution of pharmaceuticals, quasi-drugs, cosmetics and other products
LocationMakati City, Philippines / Dagupan City, Philippines
Alliance start date29 May 2026 (grand opening of the first concept store)Share Acquisition Date and Payment DateCapital contribution made in January 2026 (specific date Not disclosed)
| Item | Details |
|---|---|
| Name of alliance partner | AC HEALTH PHARMA VENTURES, INC., JOLECO RESOURCES, INC. |
| Alliance partner's business activities | Operation of an integrated pharmaceutical network with a portfolio spanning the entire pharmaceutical value chain, including pharmaceutical imports, wholesale distribution and retailing, Operation of the St. Joseph Drug pharmacy chain in northern and central Luzon, Philippines, as well as the retail and wholesale distribution of pharmaceuticals, quasi-drugs, cosmetics and other products |
| Alliance partner's location | Makati City, Philippines, Dagupan City, Philippines |
| Type of alliance | Establishment of a joint venture |
| Details of the alliance | Support for importing our products and obtaining product registrations, Providing access to suppliers, Providing expertise in marketing and store development in the Philippine market, Establishment and operation of concept stores, Sales of pharmaceuticals, health foods, cosmetics and other products |
| Overview of the joint venture | Name AJS Pharma, Inc. / Location 3rd Floor Makati Stock Exchange Building, 6767 Ayala Avenue, Makati City, Philippines / Business Description Establishment and operation of concept stores, and sales of pharmaceuticals, health foods, cosmetics and other products / Capital Contributions Not disclosed / Ownership ratio Our company 40%, APV 40%, JRI 20% |
| Ownership ratio | Our company 40%, APV 40%, JRI 20% |
| Alliance start date | 29 May 2026 (grand opening of the first concept store) |
| Share Acquisition Date and Payment Date | Capital contribution made in January 2026 (specific date Not disclosed) |
Items this document does not state (14)
Alliance partner's capitalAlliance partner's net salesAlliance partner's operating incomeNumber of shares acquiredAcquisition priceShareholding ratioDispatch of directors and officersContract PeriodNumerical targets under the allianceShareholding PolicyDate of board resolutionContract DateImpact on Business PerformanceChange in major shareholders
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To combine the strengths of the respective companies and develop the business in the Philippine market, delivering high-quality, affordable Japanese healthcare products to households in the Philippines.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.